GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Boston Scientific Corporation (BSX) [hlAlert]

Rating:
Neutral BSX
up 60.48 %

Boston Scientific Corporation (BSX) downgraded to Neutral by Citigroup

Posted on: Monday,  Jul 8, 2013  8:25 AM ET by Citigroup

Citigroup rated Neutral Boston Scientific Corporation (NYSE: BSX) on 07/08/2013. Previously Citigroup rated Buy Boston Scientific Corporation (NYSE: BSX) on 11/26/2012.,
when the stock price was $5.77. Since then, Boston Scientific Corporation has gained 60.49% as of 07/08/2013's recent price of $9.26.
If you would have followed the previous Citigroup's recommendation on BSX, you would have gained 60.48% of your investment in 224 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/8/2013 8:25 AM Hold
None
9.26
as of 12/13/2013
1 Week   
1 Month   
3 Months   
1 YTD up  61.60 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/26/2012 10:25 AM Buy
None
5.77
2/6/2008 8:25 AM Hold
None
12.63

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy